近年来，诱导多能干细胞（iPSC）在医学研究和临床治疗中展现出了巨大的潜力，市场关注度持续升温。仅在2024年，全球范围内针对iPSC相关企业的融资总额已超过80亿美元，较前一年增长近60%，融资额在“资本寒冬”中逆势上扬。

Attorneys for two NFL entities and a former NFL Enterprises LLC director who sued alleging age and gender discrimination are ...